关节型银屑病,抗风湿药,生物制剂 ," /> 关节型银屑病,抗风湿药,生物制剂 ,"/> psoriatic arthritis,disease-modifying antirheumatic drugs,biologic agents ,"/> <p class="MsoNormal"> Update of pharmacological treatment of psoriatic arthritis

China Journal of Leprosy and Skin Diseases ›› 2017, Vol. 33 ›› Issue (4): 245-248.

Previous Articles     Next Articles

Update of pharmacological treatment of psoriatic arthritis

XIONG   Fei1,2, YANG Qing2   

  1. 1. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250062, China; 2. Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, 250022, China

  • Online:2017-04-15 Published:2018-12-19
  • Contact: YANG Qing, E-mail: yangqing79@126.com

Abstract:

Psoriatic arthritis (PsA) is a chronic inflammatory disease, which affects the skin and joints. Therapy drugs include nonsteroidal anti-inflammatory agents (NSAID), disease-modifying antirheumatic drugs (DMARDs) and biologic agents. The effects and adverse reactions of those drugs in the treatment of PsA were reviewed in this article

Key words: psoriatic arthritis')">

psoriatic arthritis, disease-modifying antirheumatic drugs, biologic agents